JPH0859488A - Health promotive agent - Google Patents

Health promotive agent

Info

Publication number
JPH0859488A
JPH0859488A JP6211785A JP21178594A JPH0859488A JP H0859488 A JPH0859488 A JP H0859488A JP 6211785 A JP6211785 A JP 6211785A JP 21178594 A JP21178594 A JP 21178594A JP H0859488 A JPH0859488 A JP H0859488A
Authority
JP
Japan
Prior art keywords
feldspar
wacke
sandstone
belonging
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6211785A
Other languages
Japanese (ja)
Inventor
Masatoshi Nakano
昌俊 中野
Kazuyuki Torii
一之 鳥井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP6211785A priority Critical patent/JPH0859488A/en
Publication of JPH0859488A publication Critical patent/JPH0859488A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PURPOSE: To obtain a health promotive agent free from side effects, having excellent efficacy as a therapeutic agent for diabetes, rheumatism, hepatopathy, atopic dermatitis, constipation, nephropathy, hypertension, lumbago, skin chapping, cancer or wound. CONSTITUTION: This health promotive agent, which contains oxides composed of 64.1wt.% of SiO2 , 20.2wt.% of Al2 O3 , 7.46wt.% of K2 O, 0.68wt.% of CaO and 0.73wt.% of MgO and rare earth microelements found in rock composed of 0.022wt.% of Ni, 0.033wt.% of Rb, 0.009wt.% of Sb, 0.021wt.% of Cs, 0.020wt.% of Pb, 0.016wt.% of Bi, 0.007 wt.% of Y, 0.013wt.% of La, 0.017wt.% of Ba, 0.008wt.% of Zn and 0.004wt.% of Cu, consists mainly of feldspathic sandstone or feldspathic wacke radiating electromagnetic waves such as γ-rays and IR rays and black-body radiation.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、長石質砂岩または長石
質ワッケに属する天然堆積岩含を有効成分とする健康増
進剤、治療剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a health promoting agent and a therapeutic agent containing as an active ingredient natural sedimentary rocks belonging to feldspar sandstone or feldspar wacke.

【0002】[0002]

【従来の技術】従来より,健康増進機器、健康食品、健
康補助剤、栄養剤として多くの製品が知られている。
2. Description of the Related Art Conventionally, many products have been known as health promotion equipment, health foods, health supplements and nutritional supplements.

【0003】[0003]

【発明が解決しようとする課題】しかし、従来の健康補
助剤等は、健康食品、健康補助剤、栄養剤としてさまざ
まなものを加工する必要があり、また、効力の疑わしい
ものや、効力の弱いものがほとんどで、効果があるもの
は副作用が生ずるため、健康を維持し、成人病を予防改
善することは難しく、また、効果が薄いため効果を得る
のに長時間要する欠点があった。
However, it is necessary to process various conventional health supplements such as health foods, health supplements, and nutritional supplements, and those with doubtful efficacy and weak efficacy. Most of them are effective and side effects occur, so that it is difficult to maintain health and prevent and improve adult diseases. Further, the effects are weak and it takes a long time to obtain the effects.

【0004】また、近年、各種治療剤が開発されている
が、副作用が著しいため副作用の比較的少ない天然の植
物等の抽出液を用いたものが開発されている。しかし、
天然に産出する堆積岩を用いた製品で著しい効果を挙げ
ているものは知られていない。
Further, in recent years, various therapeutic agents have been developed, but those using an extract of a natural plant or the like having relatively few side effects have been developed because of significant side effects. But,
None of the products using naturally occurring sedimentary rocks are known to have a significant effect.

【0005】本発明は、副作用がなく、細胞機能を活発
にして身体のホメオスタシスを維持する健康増進剤、各
種治療剤を天然に産出する堆積岩から提供することを目
的とする。
It is an object of the present invention to provide a health promoting agent for activating cell functions and maintaining homeostasis of the body without side effects, and various therapeutic agents from naturally occurring sedimentary rocks.

【0006】[0006]

【課題を解決するための手段】そこで、本発明者らは、
前記目的を解決するために鋭意研究を重ねた結果、天然
に産出する堆積岩の一種で、長石質砂岩または長石質ワ
ッケに属する天然堆積岩石を主成分とするものが各種疾
患に優れた効果を得るとの知見を得た。
Therefore, the present inventors have
As a result of intensive research to solve the above-mentioned object, one of naturally occurring sedimentary rocks, which mainly consists of natural sedimentary rocks belonging to feldspar sandstone or feldspar wacke, has excellent effects on various diseases. I got the knowledge.

【0007】つまり、長石質砂岩または長石質ワッケに
属する天然堆積岩石から得られ、酸化物としてSi
2,64.1%;Al23,20.2%;K2O,7.
46%;CaO,0.68%;MgO,0.73%;M
nO,0.12%;TiO2,0.75%;Fe23
7.46%;Cr23,0.09%;を含有することが
好ましく、また、岩石含有稀土類微量元素の組成比率が
Ni,0.022%;Rb,0.033%,Sb,0.
009%;Cs,0.021%;Pb,0.020%,
Bi,0.016%;Y,0.007%;La,0.0
13%;Ba,0.017%;Zn,0.008%;C
u,0.004;を含有し、さらにγ線、赤外線などの
電磁波および黒体放射を放射する組成物が、広範な疾患
に対して優れた効果を有し、かつ副作用がなく安全且つ
迅速に健康を維持しかつ成人病および/または老人病の
改善と治療ができるとの知見を得て本発明を完成した。
[0007] That is, obtained from natural sedimentary rocks belonging to feldspar sandstone or feldspar wacke, Si as an oxide
O 2, 64.1%; Al 2 O 3, 20.2%; K 2 O, 7.
46%; CaO, 0.68%; MgO, 0.73%; M
nO, 0.12%; TiO 2 , 0.75%; Fe 2 O 3 ,
7.46%; Cr 2 O 3 , 0.09%; is preferable, and the composition ratio of the rare earth trace element containing rock is Ni, 0.022%; Rb, 0.033%, Sb, 0.
009%; Cs, 0.021%; Pb, 0.020%,
Bi, 0.016%; Y, 0.007%; La, 0.0
13%; Ba, 0.017%; Zn, 0.008%; C
u, 0.004; and further radiates electromagnetic waves such as γ rays and infrared rays and black body radiation, has excellent effects on a wide range of diseases, and is safe and quick without side effects. The present invention has been completed based on the finding that it is possible to maintain health and improve and treat adult diseases and / or geriatric diseases.

【0008】本発明の有効成分は、前記岩石そのまま、
あるいは岩石を微細に粉砕することによって、また、微
細顆粒に、さらにセラミック加工や、錠剤化、乳剤、ゼ
リー状、など任意の形態で単独、または、他の飲食物あ
るいは天然および/または加工製品に加工して用いるこ
ともできるが、好ましくは、微粉末を水に溶解した組成
物を得るのが望ましい。
The active ingredient of the present invention is
Alternatively, by finely crushing rocks, fine granules, ceramic processing, tableting, emulsion, jelly, etc. alone or in any other form of food or drink or natural and / or processed products Although it can be processed and used, it is preferable to obtain a composition in which fine powder is dissolved in water.

【0009】また、岩石、微粉末あるいは加工品を水に
浸してその水を飲食してもよく、その水を各種お茶、コ
ーヒーなどと共に利用してもよい。
Further, rocks, fine powder or processed products may be dipped in water to eat or drink the water, and the water may be used together with various teas, coffees and the like.

【0010】さらに、皮膚疾患等に関しては、岩石、微
粉末あるいは加工品を浴槽に入れることよって用いるこ
ともできる。
Further, for skin diseases and the like, rocks, fine powders or processed products can be used by putting them in a bath.

【0011】本発明の構成物質はいずれも無毒性のもの
で薬理基準にも合致したもので、ラットに対する急性毒
性試験で死亡例は皆無であり、生化学血液検査および病
理組織学的検査においても異常が認められなかった。
All of the constituents of the present invention are non-toxic and meet the pharmacological criteria. There are no deaths in the acute toxicity test for rats, and no biochemical blood test or histopathological test is performed. No abnormality was found.

【0012】飲食用として用いる場合の投与量は、対象
となる疾患の種類、程度により異なるが、岩石の微粉末
をそのまま用いるときは、0.1〜50mg/kg体重
/日の範囲で用いるのが好ましい。また、水溶液として
用いるときは、0.1〜1000ppm溶液を100〜
1000ml/日飲食するのが好ましい。岩石そのもの
を水に浸した液を飲料水として用いる場合には、0.1
g〜100g/100mlの水に浸した濃度の水を飲食
するのが好ましい。
When used as a food or drink, the dose varies depending on the kind and degree of the target disease, but when rock fine powder is used as it is, it is used in the range of 0.1 to 50 mg / kg body weight / day. Is preferred. When used as an aqueous solution, a solution of 0.1 to 1000 ppm is added to 100 to
It is preferable to eat and drink 1000 ml / day. When using the liquid in which the rock itself is immersed in water as drinking water, 0.1
It is preferable to eat and drink water having a concentration immersed in g to 100 g / 100 ml of water.

【0013】さらに、浴槽などに使用する場合は、通常
の家庭用浴槽の場合には岩石そのものあるいはセラミッ
ク加工したもの5g〜10kgを浴槽内設置するのが好ま
しく、また浴槽枠を当岩石で敷き詰めるかあるいはセラ
ミック加工品微粒子を浴槽内入れてサンドバスとするこ
とが好ましい。
Further, when it is used in a bathtub or the like, in the case of an ordinary domestic bathtub, it is preferable to install 5 g to 10 kg of rock itself or ceramic-processed one in the bathtub, and whether the bath frame is covered with this rock. Alternatively, it is preferable to put fine particles of ceramic processed product in a bath to form a sand bath.

【0014】[0014]

【作用】成人病および/あるいは老年病の発症要因は複
雑で不明な点が多いが、多くの疾患はミネラルバランス
の異常によって生じる可能性がある。本発明は、特異な
岩石組成による赤外線放射によっておよび/または微量
ミネラルによって細胞を活性化する作用が組み合わさっ
て作用していると考えられる。
[Advantages] The etiological factors of adult diseases and / or geriatric diseases are complex and unclear, but many diseases may be caused by abnormal mineral balance. The present invention is believed to work in combination with the action of activating cells by infrared radiation and / or by trace minerals due to the unique rock composition.

【0015】[0015]

【効果】本発明は、ヒトの成人病および/または老年病
などの疾患だけでなく各種哺乳動物、鳥類、魚類の疾患
を副作用無く、飲食等による内服として、また岩石その
ものおよび/またはセラミック加工品を浴槽に使用する
ことで迅速に各種疾患を改善することができる。そし
て、特に、健康増進剤として、また、糖尿病治療剤、リ
ウマチ治療剤、肝臓病治療剤、アトピー性皮膚炎治療
剤、便秘治療剤、腎臓病治療剤、高血圧治療剤、腰痛治
療剤、肌荒れ治療剤、癌治療剤、創傷治療剤として優れ
た効果を有する。
[Effect] The present invention can treat not only human diseases such as adult diseases and / or senile diseases but also diseases of various mammals, birds, and fishes without side effects, as oral administration by eating and drinking, and rocks and / or ceramic processed products. It is possible to quickly improve various diseases by using the water bath in the bathtub. And, in particular, as a health-promoting agent, a therapeutic agent for diabetes, a therapeutic agent for rheumatism, a therapeutic agent for liver disease, a therapeutic agent for atopic dermatitis, a therapeutic agent for constipation, a therapeutic agent for kidney disease, a therapeutic agent for hypertension, a therapeutic agent for low back pain, and a treatment for rough skin. It has excellent effects as an agent, a therapeutic agent for cancer and a therapeutic agent for wounds.

【0016】[0016]

【実施例】【Example】

製造例 長石質砂岩または長石質ワッケに属する天然堆積岩石か
ら、酸化物としてSiO2,64.1%;Al23,2
0.2%;K2O,7.46%;CaO,0.68%;
MgO,0.73%;MnO,0.12%;TiO2
0.75%;Fe23,7.46%;Cr23,0.0
9%;を含有し、岩石含有稀土類微量元素の組成比率が
Ni,0.022%;Rb,0.033%,Sb,0.
009%;Cs,0.021%;Pb,0.020%,
Bi,0.016%;Y,0.007%;La,0.0
13%;Ba,0.017%;Zn,0.008%;C
u,0.004;を含有し、さらにγ線、赤外線などの
電磁波および黒体放射を放射する天然に産出する長石質
砂岩または長石質ワッケ岩石そのものを5μ以下の微粉
末とした。また、同様の組成の岩石を慣用手段によりセ
ラミック加工品を得た。
Production example From natural sedimentary rocks belonging to feldspar sandstone or feldspar wacke, SiO 2 as an oxide, 64.1%; Al 2 O 3 , 2
0.2%; K 2 O, 7.46%; CaO, 0.68%;
MgO, 0.73%; MnO, 0.12%; TiO 2 ,
0.75%; Fe 2 O 3 , 7.46%; Cr 2 O 3 , 0.0
9%; and the composition ratio of the rock-containing rare earth trace elements is Ni, 0.022%; Rb, 0.033%, Sb, 0.
009%; Cs, 0.021%; Pb, 0.020%,
Bi, 0.016%; Y, 0.007%; La, 0.0
13%; Ba, 0.017%; Zn, 0.008%; C
u, 0.004; and radiates electromagnetic waves such as γ rays and infrared rays and black body radiation, and naturally produced feldspar sandstone or feldspar wacke rock itself was made into a fine powder of 5 μm or less. Further, a rock processed product having a similar composition was obtained by a conventional method.

【0017】実施例1 製造例で得た微粉末(5μ以下)5mgを表1に示す各種
疾患の患者に、一日約500mlを2週間飲用した後、
症状の改善を調べた。その結果、高い率で症状の改善が
認められ、飲食前に比して、健康状態が改善し、糖尿
病、リウマチ、癌などの各種疾患の症状が改善され、日
常生活に支障もなくなった。
Example 1 5 mg of the fine powder (5 μm or less) obtained in the production example was given to patients with various diseases shown in Table 1 and about 500 ml per day was drunk for 2 weeks.
I investigated the improvement of my symptoms. As a result, the symptoms were improved at a high rate, the health condition was improved compared to before eating and drinking, the symptoms of various diseases such as diabetes, rheumatism, and cancer were improved, and there was no hindrance to daily life.

【0018】[0018]

【表1】 [Table 1]

【0019】実施例2 2m×1.5m、深さ70cmの風呂桶に、製造例で得た
セラミック加工した微粒子(直径1〜3mm)を満たした
サンドバスにそれぞれリウマチ患者、腰痛患者、アトピ
ー性皮膚炎などの患者を7名づつ入浴させ症状の改善を
調べた。その結果、いずれも6名以上の高い率で症状の
改善が認められ、利用前に比して、健康状態がよくな
り、腰痛、リウマチなどの各種疾患の症状が改善され、
日常生活に支障もなくなった。
Example 2 A bathtub having a size of 2 m × 1.5 m and a depth of 70 cm, and a sand bath filled with the ceramic-processed fine particles (diameter 1 to 3 mm) obtained in the production example were used for rheumatism patients, low back pain patients, and atopic properties, respectively. Seven patients with dermatitis and so on were bathed, and the improvement in symptoms was examined. As a result, the symptoms were improved at a high rate of 6 or more in all cases, the health condition was improved compared to before use, and the symptoms of various diseases such as low back pain and rheumatism were improved,
There is no hindrance to everyday life.

【0020】実施例3 約2リットル容器に水を満たし、その中に製造例で得た
岩石あるいはセラミック加工した微粒子(直径3〜5m
m)を入れて放置した。当該発明品水溶液を便秘のもの
30名、癌のもの5名に通常の水の代わりに飲ませたと
ころ、85%以上で症状が著しく改善し、日常生活に支
障もなくなった。また、ナイフによる傷口にガーゼを起
き当該発明品水溶液をガーゼの上から浸したところ傷口
の改善が著しく早くなった。また、微粒子を5μの微粉
末に替えて同様に試験を行なったところ、同様な効果が
得られた。
Example 3 A container of about 2 liters was filled with water, and the rock or ceramic fine particles obtained in the production example (diameter 3 to 5 m) were filled therein.
m) was put and left. When 30 people with constipation and 5 people with cancer were allowed to drink the aqueous solution of the present invention instead of normal water, the symptom was remarkably improved at 85% or more, and there was no hindrance to daily life. In addition, when gauze was generated in the wound with a knife and the aqueous solution of the invention was soaked over the gauze, the improvement of the wound was significantly accelerated. Further, when the same test was performed by changing the fine particles to a fine powder of 5 μm, the same effect was obtained.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 35/02 ADU 7431−4C 33/00 ADA 33/06 AAG 33/24 ACS 51/00 ACQ C02F 1/68 510 B H Z 520 K // A23L 1/30 Z ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification number Reference number within the agency FI Technical display area A61K 35/02 ADU 7431-4C 33/00 ADA 33/06 AAG 33/24 ACS 51/00 ACQ C02F 1/68 510 B H Z 520 K // A23L 1/30 Z

Claims (14)

【特許請求の範囲】[Claims] 【請求項1】 長石質砂岩または長石質ワッケに属する
天然堆積岩石を主成分とする健康増進剤。
1. A health-enhancing agent which is mainly composed of natural sedimentary rocks belonging to feldspar sandstone or feldspar wacke.
【請求項2】 酸化物としてSiO2,64.1%;A
23,20.2%;K2O,7.46%;CaO,
0.68%;MgO,0.73%を含有する長石質砂岩
または長石質ワッケを主成分とする健康増進剤。
2. SiO 2 as an oxide, 64.1%; A
l 2 O 3 , 20.2%; K 2 O, 7.46%; CaO,
0.68%; Health promoting agent containing feldspar sandstone or feldspar wacke as a main component, containing MgO, 0.73%.
【請求項3】 岩石含有稀土類微量元素の組成比率がN
i,0.022%;Rb,0.033%,Sb,0.0
09%;Cs,0.021%;Pb,0.020%,B
i,0.016%;Y,0.007%;La,0.01
3%;Ba,0.017%;Zn,0.008%;C
u,0.004;を含有し、さらにγ線、赤外線などの
電磁波および黒体放射を放射する請求項1または2記載
の長石質砂岩または長石質ワッケを主成分とする健康増
進剤。
3. The composition ratio of the rare earth trace element containing rock is N.
i, 0.022%; Rb, 0.033%, Sb, 0.0
09%; Cs, 0.021%; Pb, 0.020%, B
i, 0.016%; Y, 0.007%; La, 0.01
3%; Ba, 0.017%; Zn, 0.008%; C
u, 0.004; and further emits electromagnetic waves such as γ rays and infrared rays and black body radiation, and the health promoting agent containing feldspar sandstone or feldspar wacke as a main component according to claim 1 or 2.
【請求項4】 長石質砂岩または長石質ワッケに属する
天然堆積岩石を主成分とする糖尿病治療剤。
4. A therapeutic agent for diabetes which is mainly composed of natural sedimentary rocks belonging to feldspar sandstone or feldspar wacke.
【請求項5】 長石質砂岩または長石質ワッケに属する
天然堆積岩石を主成分とするリウマチ治療剤。
5. A therapeutic agent for rheumatism, which is mainly composed of natural sedimentary rocks belonging to feldspar sandstone or feldspar wacke.
【請求項6】 長石質砂岩または長石質ワッケに属する
天然堆積岩石を主成分とする肝臓病治療剤。
6. A therapeutic agent for liver diseases, which is mainly composed of natural sedimentary rocks belonging to feldspar sandstone or feldspar wacke.
【請求項7】 長石質砂岩または長石質ワッケに属する
天然堆積岩石を主成分とするアトピー性皮膚炎治療剤。
7. A therapeutic agent for atopic dermatitis, which comprises a natural sedimentary rock belonging to feldspar sandstone or feldspar wacke as a main component.
【請求項8】 長石質砂岩または長石質ワッケに属する
天然堆積岩石を主成分とする便秘治療剤。
8. A remedy for constipation comprising, as a main component, natural sedimentary rocks belonging to feldspar sandstone or feldspar wacke.
【請求項9】 長石質砂岩または長石質ワッケに属する
天然堆積岩石を主成分とする腎臓病治療剤。
9. A remedy for renal diseases, which is mainly composed of natural sedimentary rocks belonging to feldspar sandstone or feldspar wacke.
【請求項10】 長石質砂岩または長石質ワッケに属す
る天然堆積岩石を主成分とする高血圧治療剤。
10. A therapeutic agent for hypertension, which is mainly composed of natural sedimentary rocks belonging to feldspar sandstone or feldspar wacke.
【請求項11】 長石質砂岩または長石質ワッケに属す
る天然堆積岩石を主成分とする腰痛治療剤。
11. A therapeutic agent for low back pain, which comprises a natural sedimentary rock belonging to feldspar sandstone or feldspar wacke as a main component.
【請求項12】 長石質砂岩または長石質ワッケに属す
る天然堆積岩石を主成分とする肌荒れ治療剤。
12. A skin roughening remedy mainly composed of natural sedimentary rocks belonging to feldspar sandstone or feldspar wacke.
【請求項13】 長石質砂岩または長石質ワッケに属す
る天然堆積岩石を主成分とする癌治療剤。
13. A therapeutic agent for cancer comprising, as a main component, natural sedimentary rock belonging to feldspar sandstone or feldspar wacke.
【請求項14】 長石質砂岩または長石質ワッケに属す
る天然堆積岩石を主成分とする創傷治療剤。
14. A wound healing agent containing, as a main component, a natural sedimentary rock belonging to feldspar sandstone or feldspar wacke.
JP6211785A 1994-08-12 1994-08-12 Health promotive agent Pending JPH0859488A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6211785A JPH0859488A (en) 1994-08-12 1994-08-12 Health promotive agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6211785A JPH0859488A (en) 1994-08-12 1994-08-12 Health promotive agent

Publications (1)

Publication Number Publication Date
JPH0859488A true JPH0859488A (en) 1996-03-05

Family

ID=16611570

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6211785A Pending JPH0859488A (en) 1994-08-12 1994-08-12 Health promotive agent

Country Status (1)

Country Link
JP (1) JPH0859488A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742739A1 (en) * 1995-12-25 1997-06-27 Kozo Niwa FAR INFRARED RADIATION MATERIAL, AND DRUG AND FOOD DERIVED FROM IT
WO1999039771A1 (en) * 1998-02-05 1999-08-12 Morishige, Fumie Therapeutic instrument for treating or relieving psoriasis, atopic dermatitis, articular rheumatism and/or cancer or preventing the progress of these diseases and method of utilization thereof
JP2000166509A (en) * 1998-10-02 2000-06-20 Seimei Bunshi Kasseika Kenkyusho:Kk Health food and its production
JP2011132128A (en) * 2009-12-22 2011-07-07 Katsuaki Uno Inhibiter

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742739A1 (en) * 1995-12-25 1997-06-27 Kozo Niwa FAR INFRARED RADIATION MATERIAL, AND DRUG AND FOOD DERIVED FROM IT
NL1004878C2 (en) * 1995-12-25 1998-03-06 Kozo Niwa Far infrared radiation material and drug and food product made therefrom as well as a method of making it.
BE1010468A5 (en) * 1995-12-25 1998-09-01 Kozo Niwa Material far infrared radiation and its applications.
US6004588A (en) * 1995-12-25 1999-12-21 Torii; Kazuyuki Far-infrared radiation material
AU727635B2 (en) * 1995-12-25 2000-12-14 Kozo Niwa Far-infrared radiation material and medicine and food derived therefrom
WO1999039771A1 (en) * 1998-02-05 1999-08-12 Morishige, Fumie Therapeutic instrument for treating or relieving psoriasis, atopic dermatitis, articular rheumatism and/or cancer or preventing the progress of these diseases and method of utilization thereof
US6454695B1 (en) 1998-02-05 2002-09-24 Fumie Morishige Therapeutic instrument for treating or relieving psoriasis, atopic dermatitis, articular rheumatism and/or cancer or preventing the progress of these diseases and method of utilization thereof
JP2000166509A (en) * 1998-10-02 2000-06-20 Seimei Bunshi Kasseika Kenkyusho:Kk Health food and its production
JP2011132128A (en) * 2009-12-22 2011-07-07 Katsuaki Uno Inhibiter

Similar Documents

Publication Publication Date Title
CN101889679B (en) Composition with disintoxicating and liver-protecting effects and application thereof in food and health-care food
Graham Modern Domestic Medicine...
KR102121153B1 (en) Dietary herbal composition, dietary herbal medicine pill comprising the same and method for manufacturing thereof
ES2871381T3 (en) Composition to prevent and treat cancer-related fatigue, containing processed ginseng powder or processed ginseng extract that has an enhanced ginsenoside component
US5807554A (en) Herbal formulations with nacre
WO2013073644A1 (en) Combination health and functional food product comprising multiple minerals
JPH0859488A (en) Health promotive agent
JP2972343B2 (en) Turtle and turtle composition
EP2682123A2 (en) Biologically active food additive for normalizing the function of the thyroid gland
CN107296265A (en) Accurate food synthetic balancing technique
CN1732996B (en) Oral liquid containing nanometer grade pearl powder
JPH0859487A (en) Therapeutic agent for cerebral metabolism promotion and cerebrak function improvement
Knishinsky The clay cure: Natural healing from the earth
CN101869642B (en) Chinese medicinal composition
KR100614107B1 (en) The method for manufacturing of Ceramics and It's use
KR102644868B1 (en) Compositions having antimicrobial and fungicidal effect and method for manufacturing the compositions
JP3343716B2 (en) Throat health tea and its manufacturing method
Dock Text-book of materia medica for nurses
Hutchison The elements of medical treatment
KR20010017629A (en) Composition of healthfood for stamina-enhancement
JP2819119B2 (en) Healthy tea
Barbara et al. The role of colloidal bismuth subcitrate in the short-term treatment of duodenal ulcer
Andrew A cyclopedia of domestic medicine and surgery
Kale Further trials of mebendazole and metrifonate in the treatment of onchocerciasis
KR100552263B1 (en) Tea Bag Additives Providing Alkaline Mineral Water

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040727

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20041124